Abbott Laboratories vs. XBiotech Inc
Abbott Laboratories (ABT) comes out ahead, leading on 4 of 5 compared factors.
Size & Scale
| ABT | XBIT | |
|---|---|---|
| Market Cap | $201.83 billion | $69.51 million |
| Revenue (TTM) | $46.59 billion | — |
| Net Income (TTM) | $5.42 billion | $-45,133,000 |
ABT leads on 2 of 2 size & scale factors.
Valuation
| ABT | XBIT | |
|---|---|---|
| P/E Ratio | 37.75 | — |
| Price / Book | 3.90 | 0.54 |
| Price / Sales | 4.33 | — |
XBIT leads on 1 of 1 valuation factors.
Profitability
| ABT | XBIT | |
|---|---|---|
| Net Margin | 11.65% | — |
| Return on Equity | 10.48% | -35.13% |
ABT leads on 1 of 1 profitability factors.
Dividend
| ABT | XBIT | |
|---|---|---|
| Dividend Yield | 2.16% | — |
| Payout Ratio | 81.55 | — |
ABT and XBIT split the dividend factors evenly.
Risk & Sentiment
| ABT | XBIT | |
|---|---|---|
| Short Interest | 0.57% | 17.67% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, XBIT overview, XBIT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.